FDA Warning Letters Study

Similar documents
2/17/2018. Prof. Steven S. Saliterman Department of Biomedical Engineering, University of Minnesota

Prof. Steven S. Saliterman. Department of Biomedical Engineering, University of Minnesota

Preparing a US FDA Medical Device 510(K) Submission

Mark M. Yacura. Partner

Planning For The FDA s 'Deeming Rule' For E- Cigarettes

FDA Foods Program Update

Use of Standards in Substantial Equivalence Determinations

April 25, 2014 Reference No. HAMB FDA Transparency Initiative Regulations Development

FDA Regulation of Diagnostic Tests Jeffrey N. Gibbs Hyman, Phelps & McNamara, P.C. Washington, DC

Medical Device Approval and Product Recalls

CO SPONSORED BY. November 14, 2018 DoubleTree by Hilton Hotel Rochester Rochester, MN

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update

FOOD AND DRUGS AUTHORITY (FDA) GHANA

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch

Inspections, Compliance, Enforcement, and Criminal Investigations

CDER Compliance Update

What Antivirals Can Be Used for 2009 H1N1 Influenza?

Quality Assurance Standard. Implemented 1991 Revised Version 3.0

Overview of FDA Oversight and Enforcement on Drug Compounding

The Reprocessing of Single- Use Medical Devices; Regulations Coming to Europe? CleanMed Europe Malmo, Sweden 26 September 2012

Overview of Dietary Supplement GMP Inspection Trends Quality Session 6

Primer: Medical Device User Fee Amendments Han Zhong l September 2011

Public Health Service Food and Drug Administration San Francisco District 1431 Harbor Bay Parkway Alameda, CA Telephone: 510/

Tobacco Product Applications: FDA Perspective

Raritan Pharmaceuticals, Inc. 6/20/17

A better way to speed the adoption of vaccines

Update from FDA Office of Regulatory Affairs

Overview of Regulatory Science of Food Contact Substances

Medical Devices and the Public s Health: The FDA 510(k) Clearance Process at 35 Years. Written Statement of

Best Practices in FDA 483 and Warning Letter Management and Recovery

Official Gazette of the Republic of Iraq. Contents of No. 4318

FDA Basics FDA s Import Operations: How FDA Regulates Imported Products

An Epic Battle Pharmacist Heroes vs. Shortages

Mini Summit XIV: Clinical Trial Disclosure and Results Reporting Liability under FDAAA, Section 801

STATEMENT OF JOSHUA M. SHARFSTEIN, M.D. PRINCIPAL DEPUTY COMMISSIONER U.S. FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES

2017/ /20 SERVICE PLAN

Determining Whether A Dietary Supplement Study Requires an Investigational New Drug (IND)

Via RE: 2014 Draft National Food Safety Standard General Standard for Sports Nutrition Food

Draft Guidance for Industry and FDA Staff

RECALL INDEX 2016 Q2

Engaging with FDA: A Guide for Foundation Funders of Research. FasterCures Webinar Series presents. April 18, 2012

HOT BUTTON AREAS FOR FDA ENFORCEMENT ANNE K. WALSH DIRECTOR HYMAN, PHELPS & MCNAMARA, P.C.


Quality. Guaranteeing High Quality. Outsourced Pharmacy Services. Disclosure 3/18/2013

Fda Regulatory Affairs Third Edition

SOUTH DAKOTA BOARD OF REGENTS. Policy Manual

Limiting youth access to alcohol from commercial establishments

FDA Approves Novartis Single-pill Combination Drug Tekamlo To Treat High Blood Pressure.: An Article From: Transplant News [HTML] [Digital] By

Legal Q & A. Tobacco and Minors

Heng-Jung Lien 衛生福利部食品藥物管理署. Section Chief. Food and Drug Administration, Ministry of Health and Welfare

UPDATES FROM THE FDA CENTER FOR TOBACCO PRODUCTS (CTP)

Traditional Medicine: Overview on national policies and regulations of traditional medicine

Tobacco Control Efforts in Organization of Islamic Cooperation (OIC) Member Countries

Introducing NCCN Academy for Excellence & Leadership in Oncology April Program Overview

510(k) submissions. Getting US FDA clearance for your device: Improving

LAW OF MONGOLIA. 01 July, Ulaanbaatar, Mongolia LAW ON TOBACCO CONTROL CHAPTER ONE GENERAL PROVISIONS

Inspections, Compliance, Enforcement, and Criminal Investigations

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015

IRB review of device studies

Acidity-reducing Food Additive Available For License.: An Article From: Emerging Food R&D Report [HTML] [Digital]

Southern California Section & Western Compendial Discussion Group

Contra Costa County Tobacco Prevention Coalition. A Tool for Reducing Youth Access To Tobacco: The Tobacco Retailer License

Building a Strong Quality Culture

Slow The Old FDA Entangled in its own bureaucracy Alleged by some to be too friendly with the industry it was supposed to regulate 3 What is the Curre

Key CDRH Regulatory Initiatives

Perspective from HHS Offices and Programs on Women s s Health: FDA Perspective

Lao People s Democratic Republic

Inspections, Compliance, Enforcement, and Criminal Investigations

COMMITMENT TO A TOBACCO ENDGAME IN ONTARIO

RECALL / EVENT INVESTIGATION & PATIENT LOOK BACK

Strategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials: A Workshop

INTEGRITY ACTION PLAN

NDI: LOOKING BACK & AHEAD

DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Apini$r$iy -tq 5-f

IRB Policy 5 Research Activities

Associate Board Description Sheet

Comments of the Patient, Consumer, and Public Health Coalition. Strengthening the Center for Devices and Radiological Health s 510(k) Review Process

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

AFDO Conference June 9, Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide

FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality

Inspections, Compliance, Enforcement, and Criminal Investigations

LIVE INTERACTIVE YOUR DESKTOP. Food Recall Process. Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement

Smoke-free Illinois. Illinois Department of Public Health Office of Health Promotion November 27, 2007

Optimum Bioenergy International Corp. 12/21/17

Lawrence X. Yu, Ph.D. Director (acting) Office of Pharmaceutical Science Food and Drug Administration

Module 34: Legal aspects, ADI and GRAS status of food additives

I. The FCC. A. General Information

CERTIFIED MAIL RETURN RECEIPT REQUESTED. Esther Hernandez President United States Blood Bank, Inc NW 95th Avenue Miami, Florida

Food Safety Modernization Act (FSMA) Overview

CDER Compliance Update

TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17

13961/12 SB/ak 1 DG B II

Hieber's Pharmacy 12/5/17

U.S. FDA Regulations for Exporting Food to the United States. Presented by: David Lennarz President, Business Development & Operations

Inspections, Compliance, Enforcement, and Criminal Investigations

Using Recall Data to Assess the 510(k) Process

Mitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association

Report. Uganda Pharmaceutical Sector Scan JUNE 2010

Transcription:

FDA Warning Letters Study A Look at Warning Letters for Pharma/Biotech, Medical Device, and Food & Beverage Industries Since 2007 A Warning Letter is official correspondence that notifies the highest-ranking known official of a regulated company that a serious violation of organizational regulations has been committed. These letters are published on the FDA website and are available for review by other government agencies, businesses, consumers, and the media.

FDA Warning Letters Issued by Year The average growth rate for warning letters issued between 2007 and 2012 was 15.8% per year. The issuing of FDA Warning Letters increased 78% from 2007 to 2013, even with a 12.4% decrease from 2012 to 2013. Increased by an average of 15.8 % Total increase of 104 % Decreased by 12.4 % Decreased by 27.5 % per year (2007 to 2012) from 2007 to 2012 from 2012 to 2013 comparing the first 6 months of 2013 to the first 6 months of 2014 2007 2012 We wanted to understand: What industries contributed the most to the increase and why? 2012 June 30, 2014 We believe the decrease was due to fewer FDA inspections as a result of reduced funding for the FDA 1 and an industrywide freeze on manufacturers FDA fees. 1. http://www.politico.com/story/2013/02/fda-commissioner-margaret-hamburg-2013-budget-cuts-mean-less-safe-food-88241.html

Industry Comparison Tobacco Consumer Products Since FDA warning letters are made available to the public, we did some digging to find which industries accounted for the highest number of warning letters. Three industries comprised 95.72 % of all FDA warning letters that were received between 2007 and 2013. Pharmaceutical/ Biotechnology Food & Beverage Pharmaceutical/Biotechnology Medical Device Food & Beverage Medical Device

250 Pharmaceutical/ Biotechnology In 2009, FDA warning letters to Pharma/Biotech companies increased by 48.59 %. The following areas accounted for the increase (actual numbers): 28 letters for clinical investigations (failing trial research standards) 33 letters were issued due to violations of Current Good Manufacturing Practice (CGMP) 35 letters for products related to the H1N1 virus 200 150 Clinical Trials CGMP H1N1 In 2011, China s Ministry of Health adopted Good Manufacturing Practice (GMP) requirements 1 and we saw another surge in letters in the US: 100 50 0 2007 2008 2009 2010 2011 2012 2013 83 letters related to Current Good Manufacturing Practice (CGMP) 14 letters related to clinical investigations (failing trial research standards) 1. http://eng.sfda.gov.cn/ws03/cl0768/65113.html

250 200 150 100 Medical Device A steady increase in letters within the Medical Device industry resulted in the number of FDA-issued letters nearly DOUBLING from 2007 to 2012. 1 FACTOR: Each year, we ve seen an increase in consumer access to new medical device applications and modified versions of medical devices that do not require Premarket Approval (PMA) or Section 510(k) Clearances from the FDA. 2 50 0 2007 2008 2009 2010 2011 2012 2013 1. http://www.emergogroup.com/blog/2013/05/fda-data-shows-increase-warning-letters-medical-device-firms-2005 2. http://www.fda.gov/medicaldevices/productsandmedicalprocedures/deviceapprovalsandclearances/510kclearances/default.htm

Food & Beverage 400 350 300 250 200 The Food Safety Modernization Act signed by President Obama on January 4, 2011 drove a 41 % increase in letters issued to Food & Beverage companies. 1 150 100 50 0 2007 2008 2009 2010 2011 2012 2013 1. http://www.choicesmagazine.org/choices-magazine/submitted-articles/the-fdas-food-safety-modernization-act-and-its-economic-implications

A Downward Trend in 2014 There have been 267 Warning Letters issued in 2014 so far (as of June 30, 2014), which suggests a downward trend for the total amount of warning letters for the year. Among the letters received through June 2014, 44% were in the Food & Beverage industry, 26% were in the Pharma/Biotech industry, and 24% were in the Medical Device industry. 69 letters for Pharma/Biotech 65 letters for Medical Device 117 letters for Food & Beverage 16 letters for Consumer Products & Tobacco

What s in Store for 2015 and Beyond With a proposed significant budget increase for the FDA in 2015 1, we expect the number of warning letters to rise significantly for 2015 starting a new upward trend in total warning letters issued in the coming years. RESEARCH BROUGHT TO YOU BY 1 http://blogs.fda.gov/fdavoice/index.php/2014/03/whats-new-in-the-fdas-2015-budget/